03 Profile
Hansard to 11 November 2026 · 31,429 contributions indexed · 1,439 MPs & peers
All voices01 Voice · Clinician · Rare diseases
Jennifer Vittorio
M.D., associate professor of pediatrics and medical director of pediatric liver transplantation at NYU Langone Health
press citation on 1 topic since 12 Oct 2026 · last quoted 12 Oct 2026
02 Quoted on · 1 of 29 topics
Jennifer Vittorio: key facts
- Kind of voice
- Clinician
- Role
- M.D., associate professor of pediatrics and medical director of pediatric liver transplantation at NYU Langone Health
- Quoted on
- Rare diseases
- Tracked press citations
- 1
- Most recently quoted
- 12 Oct 2026
04 The signal · where Jennifer Vittorio sits on rare diseases
Ranked 49= of 100 voices quoted in the press on rare diseases, level with 51 others on 1 citation.
Ranked on press citations on this topic only, not across all topics. Joint positions share a rank.
- 1Giles LomaxSector leaderChief Executive Officer, Spinal Muscular Atrophy UK (SMA UK)9
- 2Dr Harrison CarterAcademicDirector of Screening at NHS England8
- 3=
Prof Dame Sue HillRegulatorChief Scientific Officer for England and Senior Responsible Officer for Genomics, NHS England7 - 49=Susanne MichelSector leaderVice president, head of HTA methods and evidence planning, Clinigen1
- 49=Carmen BozicAcademicM.D., Executive Vice President, Global Medicines Development and Medical Affairs, and Chief Medical Officer at Vertex1
- 49=Jennifer VittorioClinicianM.D., associate professor of pediatrics and medical director of pediatric liver transplantation at NYU Langone Health1
- 49=Ajay PatilClinicianConsultant Neuro-Ophthalmologist1
Showing the leaders and the ranks around 49=, of 100 voices · See every voice on the topic →
05 On the record · press
What Jennifer Vittorio has said
- fiercepharma.com1
Where Jennifer Vittorio has been quoted
- 01Mirum on its way to 3rd rare liver indication for Livmarlifiercepharma.com · 12 Oct 2026
Verbatim
“Cholestatic pruritus can be relentless and profoundly disruptive for people living with ultra-rare cholestatic liver diseases, yet treatment options remain limited. The magnitude and consistency of improvements in pruritus and serum bile acid levels observed in Expand are compelling, including for patients with biliary atresia.”
Related media coverage
Recent UK press coverage of their topics, not necessarily citing them directly.
- Coventry tot's heartbreaking health battle after 'extremely rare' diagnosiscoventrytelegraph.net
- Takeda launches sleep disorder pill in the US after DEA clearance removes final hurdlereuters.com
- 'Immoral lottery' - Mum's plea after losing daughter to rare diseasethewestmorlandgazette.co.uk
Doctors, nurses, allied health professionals and other registered clinicians quoted in a clinical capacity. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 12 Nov 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.